The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 15,652,255 | 562,626 | SH | SOLE | 562,626 | 0 | 0 | ||
| ALLOGENE THERAPEUTICS INC | COM | 019770106 | 46,928,245 | 22,032,040 | SH | SOLE | 22,032,040 | 0 | 0 | ||
| AN2 THERAPEUTICS INC | COM | 037326105 | 987,107 | 715,295 | SH | DFND | 0 | 715,295 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 66,286,314 | 3,457,815 | SH | SOLE | 3,457,815 | 0 | 0 | ||
| BIOHAVEN LTD | COM | G1110E107 | 18,885,841 | 505,645 | SH | SOLE | 505,645 | 0 | 0 | ||
| BIONTECH SE | SPONSORED ADS | 09075V102 | 416,870,236 | 3,658,361 | SH | SOLE | 3,658,361 | 0 | 0 | ||
| BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 335,031 | 626,109 | SH | DFND | 0 | 626,109 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 10,466,236 | 2,411,575 | SH | SOLE | 2,411,575 | 0 | 0 | ||
| CARIBOU BIOSCIENCES INC | COM | 142038108 | 7,457,785 | 4,690,431 | SH | SOLE | 4,690,431 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 4,573,725 | 349,406 | SH | SOLE | 349,406 | 0 | 0 | ||
| ESSA PHARMA INC | COM NEW | 29668H708 | 2,998,250 | 1,675,000 | SH | SOLE | 1,675,000 | 0 | 0 | ||
| GINKGO BIOWORKS HOLDINGS INC | CL A NEW | 37611X209 | 2,426 | 247 | SH | SOLE | 247 | 0 | 0 | ||
| GINKGO BIOWORKS HOLDINGS INC | CL A NEW | 37611X209 | 26,328 | 2,681 | SH | DFND | 0 | 2,681 | 0 | ||
| HALEON PLC | SPON ADS | 405552100 | 1,881,564,202 | 197,228,952 | SH | SOLE | 197,228,952 | 0 | 0 | ||
| NEXTCURE INC | COM | 65343E108 | 318,451 | 245,526 | SH | SOLE | 245,526 | 0 | 0 | ||
| NEXTCURE INC | COM | 65343E108 | 1,573,312 | 1,213,024 | SH | DFND | 0 | 1,213,024 | 0 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 43,387,096 | 5,376,344 | SH | SOLE | 5,376,344 | 0 | 0 | ||
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 9,285,530 | 5,952,263 | SH | SOLE | 9,285,530 | 0 | 0 | ||
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 1,685,591 | 1,080,507 | SH | DFND | 0 | 1,080,507 | 0 | ||
| Q32 BIO INC | COM | 746964105 | 955,553 | 277,777 | SH | SOLE | 277,777 | 0 | 0 | ||
| SENSEONICS HLDGS INC | COM | 81727U105 | 22,729 | 43,426 | SH | DFND | 0 | 43,426 | 0 | ||
| SPERO THERAPEUTICS INC | COM | 84833T103 | 2,433,218 | 2,362,348 | SH | SOLE | 2,362,348 | 0 | 0 | ||
| TOURMALINE BIO INC | COM | 89157D105 | 25,800,500 | 1,272,214 | SH | SOLE | 1,272,214 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 23,193,750 | 1,875,000 | SH | DFND | 0 | 1,875,000 | 0 | ||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 2,890,117 | 953,834 | SH | SOLE | 953,834 | 0 | 0 | ||
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 7,425,055 | 2,970,022 | SH | SOLE | 2,970,022 | 0 | 0 | ||
